Stay updated on Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page
- Check2 days agoChange DetectedThis updates the ClinicalTrials.gov page revision/version indicator (v3.5.3 instead of v3.5.0), indicating a site release change rather than a modification to the study details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedSite revision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor metadata or backend update with no visible changes to core content or user-facing features.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check95 days agoChange DetectedGlossary visibility was added and a revision tag shows v3.4.0 along with updated 'No FEAR Act Data' wording and a QC status entry. These changes are cosmetic and do not affect study content, eligibility criteria, or outcomes.SummaryDifference0.2%

Stay in the know with updates to Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib in COVID-19 Pulmonary Fibrosis Clinical Trial page.